Chargement en cours...

Alemtuzumab for multiple sclerosis

BACKGROUND: Multiple sclerosis (MS) is an autoimmune, T‐cell‐dependent, inflammatory, demyelinating disease of the central nervous system, with an unpredictable course. Current MS therapies focus on treating exacerbations, preventing new exacerbations and avoiding the progression of disability. Howe...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Cochrane Database Syst Rev
Auteurs principaux: Riera, Rachel, Porfírio, Gustavo JM, Torloni, Maria R
Format: Artigo
Langue:Inglês
Publié: John Wiley & Sons, Ltd 2016
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6486037/
https://ncbi.nlm.nih.gov/pubmed/27082500
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD011203.pub2
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!